These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21569095)

  • 1. Vaginal retention of locally administered clindamycin.
    Eriksson K; Larsson PG; Nilsson M; Forsum U
    APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study.
    Larsson PG; Platz-Christensen JJ; Dalaker K; Eriksson K; Fåhraeus L; Irminger K; Jerve F; Stray-Pedersen B; Wölner-Hanssen P
    Acta Obstet Gynecol Scand; 2000 May; 79(5):390-6. PubMed ID: 10830767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules.
    Eriksson K; Carlsson B; Forsum U; Larsson PG
    Acta Derm Venereol; 2005; 85(1):42-6. PubMed ID: 15848990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
    Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP
    Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women.
    Rosenstein IJ; Morgan DJ; Lamont RF; Sheehan M; Doré CJ; Hay PE; Taylor-Robinson D
    Infect Dis Obstet Gynecol; 2000; 8(3-4):158-65. PubMed ID: 10968599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes.
    Darwish A; Elnshar EM; Hamadeh SM; Makarem MH
    J Obstet Gynaecol Res; 2007 Dec; 33(6):781-7. PubMed ID: 18001442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis.
    Hillier S; Krohn MA; Watts DH; Wolner-Hanssen P; Eschenbach D
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):407-13. PubMed ID: 2381617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial vaginosis. Relation between the vaginal flora and the vaginal epithelial cells under different treatments. Ultrastructural study].
    Flores Rivera E; Casanova Roman G; Beltrán M; González Jimenez MA; Villegas Castrejon H
    Ginecol Obstet Mex; 1997 May; 65():182-90. PubMed ID: 9273327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.
    Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Foster-Rosales A; Cohen CR
    Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Steinmetz JI; Schumacher RJ; Joffrion JL
    Sex Transm Dis; 2007 Apr; 34(4):197-202. PubMed ID: 17179772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R; Tassone D
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial.
    Parent D; Bossens M; Bayot D; Kirkpatrick C; Graf F; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1996 Jan; 46(1):68-73. PubMed ID: 8821521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
    Donders GG; Van Calsteren K; Bellen G; Reybrouck R; Van den Bosch T; Riphagen I; Van Lierde S
    BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
    Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
    Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.